Get started
Author

Chen Benafsha

ORCID: 0009-0005-2271-8376
Observed ORCID: 0009-0005-2271-8376
OpenAlex ID: A5037101074
Activation of the EGFR / PI3K / AKT pathway limits the efficacy of trametinib treatment in head and neck cancer
2023 · Ofra Novoplansky, Avital B. Shnerb, et al. · Molecular Oncology · 34
PDF
Quaternized Starch-Based Composite Nanoparticles for siRNA Delivery to Tumors
2021 · Eliz Amar-Lewis, Nitsa Buaron, et al. · ACS Applied Nano Materials · 16
Elucidating siRNA Cellular Delivery Mechanism Mediated by Quaternized Starch Nanoparticles
2024 · Eliz Amar‐Lewis, Limor Cohen, et al. · Small · 9
PDF
Cargo-Dependent Targeted Cellular Uptake Using Quaternized Starch as a Carrier
2023 · Yossi Blitsman, Chen Benafsha, et al. · Nanomaterials · 9
PDF
The Potential of PIP3 in Enhancing Wound Healing
2024 · Yossi Blitsman, Etili Hollander, et al. · International Journal of Molecular Sciences · 5
PDF
Targeted siRNA Delivery Using Cetuximab‐Conjugated Starch for Epidermal Growth Factor Receptor‐Driven Head and Neck Squamous Cell Carcinoma
2025 · Chen Benafsha, Limor Cohen, et al. · Small Science · 2
PDF
Effect of Degree of Substitution and Molecular Weight on Transfection Efficacy of Starch-Based siRNA Delivery System
2024 · Amir Regev, Chen Benafsha, et al. · Polysaccharides · 2
PDF
Advancing Skin Rejuvenation Through Ultrasound-Enhanced Non-Invasive Delivery of Hyaluronic Acid Nanoparticles
2025 · Leah Shimonov, Chen Benafsha, et al. · Nanomaterials
PDF
Author response for "Activation of the EGFR / PI3K / AKT pathway limits the efficacy of trametinib treatment in head and neck cancer"
2023 · Ofra Novoplansky, Avital B. Shnerb, et al.
Author response for "Activation of the EGFR / PI3K / AKT pathway limits the efficacy of trametinib treatment in head and neck cancer"
2023 · Ofra Novoplansky, Avital B. Shnerb, et al.
Works count: 10
Citation count: 77
H-index: 5
I10-index: 2
Year
Topic
Type